WIT Other Income/Expenses (Net)

Wipro Limited Common Stock · Other Income/Expenses (Net)

WIT logo

WIT Other Income/Expenses (Net)

Latest reported₹18.53B INR
WIT TTM Other Income/Expenses (Net) · INR (₹892.14M → ₹18.53B)
High-resolution chart · PNG

WIT other income/expenses (net) history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Wipro Limited Common Stock Other Income/Expenses (Net) — Trailing twelve months (TTM) (INR)
Period endingOther Income/Expenses (Net) (INR)
18,531,126,000
21,900,000,000
23,854,000,000
28,106,000,000
27,691,000,000
27,767,000,000
24,873,000,000
19,002,000,000
15,681,000,000
11,799,000,000
11,111,000,000
10,469,000,000
9,929,000,000
9,880,000,000
8,051,000,000
7,657,000,000
7,792,000,000
8,739,000,000
10,989,000,000
12,105,000,000
14,530,000,000
15,821,000,000
15,954,000,000
15,892,000,000
14,776,000,000
15,448,000,000
16,782,000,000
18,196,000,000
18,378,000,000
17,357,000,000
15,505,000,000
14,060,000,000
15,257,000,000
16,950,000,000
18,180,000,000
19,527,000,000
18,941,000,000
17,338,000,000
16,477,000,000
16,227,000,000
16,743,000,000
17,795,000,000
17,980,000,000
18,211,000,000
17,567,000,000
16,958,000,000
16,260,000,000
14,811,000,000
13,500,000,000
12,136,000,000
11,651,000,000
10,634,000,000
10,145,000,000
9,784,000,000
8,039,000,000
7,925,000,000
6,749,000,000
5,316,000,000
5,737,000,000
5,383,000,000
5,618,000,000
5,803,000,000
5,366,000,000
5,524,000,000
4,889,000,000
4,535,000,000
3,899,000,000
1,775,242,000
1,492,242,000
1,038,242,000
992,242,000
1,403,654,000
1,271,117,000
1,765,285,000
2,439,980,000
3,391,497,000
3,797,220,000
3,512,631,000
2,988,846,000
2,402,711,000
2,024,014,000
1,871,022,000
1,566,981,559
1,346,564,479
1,103,466,779
707,879,779
713,872,220
948,193,958
927,606,309
1,110,672,669
767,647,876
308,383,438
279,349,568
211,259,056
332,443,849
704,357,629
888,684,225
957,278,791
1,109,451,572
892,142,572
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.